Bays HE - Search Results

1

Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials.

Leiter LA, Banach M, Catapano AL, Duell PB, Gotto AM Jr, Laufs U, Mancini GBJ, Ray KK, Hanselman JC, Ye Z, Bays HE. Leiter LA, et al. Among authors: bays he. Diabetes Obes Metab. 2022 May;24(5):868-880. doi: 10.1111/dom.14645. Epub 2022 Feb 3. Diabetes Obes Metab. 2022. PMID: 34981622 Free PMC article. Clinical Trial.

2

Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies.

Bays HE, Moore PB, Drehobl MA, Rosenblatt S, Toth PD, Dujovne CA, Knopp RH, Lipka LJ, Lebeaut AP, Yang B, Mellars LE, Cuffie-Jackson C, Veltri EP; Ezetimibe Study Group. Bays HE, et al. Clin Ther. 2001 Aug;23(8):1209-30. doi: 10.1016/s0149-2918(01)80102-8. Clin Ther. 2001. PMID: 11558859 Clinical Trial.

3

A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitus.

Bays H, McElhattan J, Bryzinski BS; GALLANT 6 Study Group. Bays H, et al. Diab Vasc Dis Res. 2007 Sep;4(3):181-93. doi: 10.3132/dvdr.2007.039. Diab Vasc Dis Res. 2007. PMID: 17907108 Free article. Clinical Trial.

4

Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.

Conard SE, Bays HE, Leiter LA, Bird SR, Rubino J, Lowe RS, Tomassini JE, Tershakovec AM. Conard SE, et al. Among authors: bays he. Am J Cardiol. 2008 Dec 1;102(11):1489-94. doi: 10.1016/j.amjcard.2008.09.075. Epub 2008 Oct 23. Am J Cardiol. 2008. PMID: 19026302 Clinical Trial.

5

Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.

Leiter LA, Bays H, Conard S, Bird S, Rubino J, Hanson ME, Tomassini JE, Tershakovec AM. Leiter LA, et al. Am J Cardiol. 2008 Dec 1;102(11):1495-501. doi: 10.1016/j.amjcard.2008.09.076. Epub 2008 Oct 23. Am J Cardiol. 2008. PMID: 19026303 Clinical Trial.

6

Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither.

Conard S, Bays H, Leiter LA, Bird S, Lin J, Hanson ME, Shah A, Tershakovec AM. Conard S, et al. Diabetes Obes Metab. 2010 Mar;12(3):210-8. doi: 10.1111/j.1463-1326.2009.01152.x. Diabetes Obes Metab. 2010. PMID: 20151997 Clinical Trial.

7

Influence of age, gender, and race on the efficacy of adding ezetimibe to atorvastatin vs. atorvastatin up-titration in patients at moderately high or high risk for coronary heart disease.

Bays HE, Conard SE, Leiter LA, Bird SR, Lowe RS, Tershakovec AM. Bays HE, et al. Int J Cardiol. 2011 Dec 1;153(2):141-7. doi: 10.1016/j.ijcard.2010.08.043. Epub 2010 Sep 15. Int J Cardiol. 2011. PMID: 20837371 Clinical Trial.

8

Attainment of Canadian and European guidelines' lipid targets with atorvastatin plus ezetimibe vs. doubling the dose of atorvastatin.

Leiter LA, Bays H, Conard S, Lin J, Hanson ME, Shah A, Tershakovec AM. Leiter LA, et al. Int J Clin Pract. 2010 Dec;64(13):1765-72. doi: 10.1111/j.1742-1241.2010.02530.x. Epub 2010 Oct 14. Int J Clin Pract. 2010. PMID: 20946261

9

Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?

Bays H, Conard S, Leiter LA, Bird S, Jensen E, Hanson ME, Shah A, Tershakovec AM. Bays H, et al. Lipids Health Dis. 2010 Nov 30;9:136. doi: 10.1186/1476-511X-9-136. Lipids Health Dis. 2010. PMID: 21118495 Free PMC article. Clinical Trial.

10

Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.

Stalenhoef AF, Davidson MH, Robinson JG, Burgess T, Duttlinger-Maddux R, Kallend D, Goldberg AC, Bays H. Stalenhoef AF, et al. Diabetes Obes Metab. 2012 Jan;14(1):30-9. doi: 10.1111/j.1463-1326.2011.01485.x. Epub 2011 Nov 21. Diabetes Obes Metab. 2012. PMID: 21819519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page